Canada to India: Kit Import Trade Route

The Canada to India Kit corridor is one of India's established pharmaceutical import routes from Canada, with 261 shipments documented worth a combined $66.2M USD. The route is dominated by ALMAC CLINICAL SERVICES. , which alone accounts for roughly 99% of all import value, reflecting the consolidated nature of Canada's kit export sector.

Across 42 active Canada suppliers, the average shipment value stands at $253.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with kit's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 17.8%, placing it at rank #20 among India's top kit import origins globally.

On the Indian buyer side, key Indian importers include PSI CRO PHARMA INDIA PRIVATE LIMITED , IQVIA RDS (INDIA) PRIVATE LIMITED , MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED and 41 others. PSI CRO PHARMA INDIA PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $65.7M USD.

India's kit imports from Canada are driven primarily by a handful of large-scale Canada manufacturers. ALMAC CLINICAL SERVICES. with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 42 active exporters signals a competitive but concentrated market — Indian buyers benefit from Canada supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALMAC CLINICAL SERVICES. , MS CATALENT PHARMA SOLUTIONS, LLC , ARTRON BIO RESEARCH INC — together account for 99% of total trade value on this route. The average shipment value of $253.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as lg3 lumateperone 42 mg (each blister contains 10 capsules) (141 kits) 30 and ab02-07-c1 anti hbsag mcab for coating (reagent) (list3 sr.no.123 for mfg diagnostics kit of hepatitis b antigen) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Canada supplier.

On the buying side, PSI CRO PHARMA INDIA PRIVATE LIMITED is the largest importer with 1 shipments worth $65.7M USD — representing 99% of all kit imports from Canada on this route. A total of 44 buyers are active on this corridor.